Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biology and Treatment of Richter Transformation. | Front Oncol | 2022 | 35392219 | PubTator, text mining | PubMed |
| The prominent role of a CDR1 somatic hypermutation for convergent IGHV3-53/3-66 antibodies in binding to SARS-CoV-2. | Emerg Microbes Infect | 2022 | 35380101 | PubTator, text mining | PubMed |
| Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma. | Biomark Res | 2022 | 35379357 | PubTator, text mining | PubMed |
| Managing the Risk of Infection in Chronic Lymphocytic Leukemia in the Era of New Therapies. | Curr Oncol Rep | 2022 | 35366167 | PubTator, text mining | PubMed |
| Prognostic value of CD20 antigen mediated immune checkpoint inhibition in patients with acute or chronic lymphocytic leukemia: A protocol for systematic review. | Medicine (Baltimore) | 2022 | 35363193 | PubTator, text mining | PubMed |
| Concurrent Presentation of Hairy Cell Leukemia and Mantle Cell Lymphoma (Leukemic Non-Nodal Variant): An Extremely Rare Composite Lymphoma. | J Hematol | 2022 | 35356636 | PubTator, text mining | PubMed |
| Subclonal heterogeneity sheds light on the transformation trajectory in IGLV3-21R110 chronic lymphocytic leukemia. | Blood Cancer J | 2022 | 35354800 | PubTator, text mining | PubMed |
| Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans. | Cell Rep | 2022 | 35354052 | PubTator, text mining | PubMed |
| Reciprocal interactions among Cobll1, PACSIN2, and SH3BP1 regulate drug resistance in chronic myeloid leukemia. | Cancer Med | 2022 | 35352878 | PubTator, text mining | PubMed |
| Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity. | Commun Biol | 2022 | 35347236 | PubTator, text mining | PubMed |
| CD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemia. | Leuk Lymphoma | 2022 | 35343368 | PubTator, text mining | PubMed |
| Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of WNT5A promoter and undetectable expression of WNT5A gene. | Epigenetics | 2022 | 35333703 | PubTator, text mining | PubMed |
| Lymphoma: New Diagnosis and Current Treatment Strategies. | J Clin Med | 2022 | 35330026 | PubTator, text mining | PubMed |
| Insight into the Molecular Basis Underlying Chromothripsis. | Int J Mol Sci | 2022 | 35328739 | PubTator, text mining | PubMed |
| Reduced Percentage of CD14dimCD16+SLAN+ Monocytes Producing TNF and IL-12 as an Immunological Sign of CLL Progression. | Int J Mol Sci | 2022 | 35328450 | PubTator, text mining | PubMed |
| The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells. | Diagnostics (Basel) | 2022 | 35328127 | PubTator, text mining | PubMed |
| PI3K Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Current Status and Future Perspectives. | Cancers (Basel) | 2022 | 35326722 | PubTator, text mining | PubMed |
| Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma. | Cancers (Basel) | 2022 | 35326640 | PubTator, text mining | PubMed |
| Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases. | Curr Oncol | 2022 | 35323322 | PubTator, text mining | PubMed |
| New insights into Human Hematopoietic Stem and Progenitor Cells via Single-Cell Omics. | Stem Cell Rev Rep | 2022 | 35318612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=33